34 Stocks Moving In Friday's Mid-Day Session

Gainers

• ZIVO Bioscience, Inc. ZIVO shares jumped 76.2% to $6.08.
• Unique Fabricating, Inc. UFAB jumped 37.7% to $3.47. Form 4 filings from late Thursday showed stock purchases from multiple company’s Directors.
• Aehr Test Systems AEHR jumped 35% to $15.91 after the company reported better-than-expected Q1 results. The company also said it sees FY21 revenue of $50 million.
• Meredith Corporation MDP shares gained 26.4% to $56.74 following reports suggesting IAC/InterActiveCorp is in advanced talks to acquire the company in a deal valued at over $2.5 billion.
• Marin Software Incorporated MRIN jumped 21% to $10.34. Marin Software recently announced a revenue share agreement with Google.
• Paltalk, Inc. PALT gained 17.2% to $3.4701. Paltalk, last month, reported Q2 earnings of $0.12 per share.
• Immuron Limited IMRN gained 14.4% to $4.75. Immuron shares dipped over 15% on Thursday as the company said it will not proceed with proposed acquisition of R&D vaccine company.
• Nisun International Enterprise Development Group Co., Ltd NISN gained 12.5% to $10.84. Nisun International reported 1H sales of $38.9 million, up 188.9% year over year.
• Progress Software Corporation PRGS climbed 11.7% to $51.60 as the company reported better-than-expected results for its third quarter and raised FY21 guidance. The company also announced acquisition of privately held Kemp for $258 million in cash.
• Condor Hospitality Trust, Inc. CDOR gained 11.1% to $6.83.
• Focus Universal Inc. FCUV climbed 10.6% to $11.87. The company’s shares jumped around 65% over the previous month.
• Canoo Inc. GOEV gained 9.6% to $8.13.
• Paratek Pharmaceuticals, Inc. PRTK jumped 8.9% to $5.33. Paratek will present new data for NUZYRA at IDWeek 2021 Wednesday, Sept. 29.
• Borr Drilling Limited BORR shares rose 8.2% to $0.7999 after gaining around 4% on Thursday.
• vTv Therapeutics Inc. VTVT gained 7.6% to $1.9050 after the company disclosed results of multiple ascending dose study and development plan for HPP737, an oral PDE4 inhibitor for the treatment of psoriasis.

Check out these big penny stock gainers and losers

Losers

• SecureWorks Corp. SCWX shares dipped 24.1% to $20.22.
• Canaan Inc. CAN fell 20.9% to $6.13 amid a decrease in the price of Bitcoin and Ethereum after China's Central Bank banned all crypto transactions and vowed to stop illegal crypto mining.
• Helbiz, Inc. HLBZ fell 18.5% to $18.75. Helbiz announced its official arrival in California.
• Onconova Therapeutics, Inc. ONTX fell 18% to $4.1885. Onconova Therapeutics priced an underwritten public offering of 5 million shares at $4.20 for gross proceeds of $21 million.
• Xos, Inc. XOS dipped 16.7% to $5.89.
• MEDIROM Healthcare Technologies Inc. MRM fell 15.5% to $10.80. MEDIROM Healthcare Technologies shares surged over 73% on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.
• InnSuites Hospitality Trust IHT fell 15.2% to $4.34 after jumping over 45% on Thursday.
• Senmiao Technology Limited AIHS shares fell 14.7% to $0.7048 after jumping over 16% on Thursday.
• aTyr Pharma, Inc. LIFE dropped 14.7% to $10.64. Piper Sandler recently initiated coverage on aTyr Pharma with an Overweight rating and announced a price target of $19.
• Cellect Biotechnology Ltd. APOP dipped 14.4% to $20.58.
• Chindata Group Holdings Limited CD fell 12.6% to $8.59.
• Nerdy, Inc. NRDY tumbled 12% to $10.16.
• Zenvia Inc. ZENV dropped 10.7% to $14.32.
• TransCode Therapeutics, Inc. RNAZ fell 9.7% to $3.6310. TransCode Therapeutics shares surged 53% on Thursday after the company announced that preclinical research supporting its lead candidate, TTX-MC138, was published in Cancer Nanotechnology.
• Hibbett, Inc. HIBB fell 9.3% to $72.38.
• Four Seasons Education (Cayman) Inc. FEDU fell 9% to $0.7551. Four Seasons Education shares climbed 43% on Thursday after the company announced board authorization to repurchase up to $15 million.
• Amplitude Healthcare Acquisition Corporation AMHC shares fell 8.7% to $13.12 after climbing over 40% on Thursday. The company announced shareholders approved the business combination with Jasper Therapeutics.
• Valneva SE VALN fell 7.4% to $31.39. Valneva said it commenced recruitment of adolescents in its pivotal Phase 3 trial for its inactivated COVID-19 vaccine candidate VLA2001 in the U.K.
• NIKE, Inc. NKE fell 6.8% to $148.73. Nike reported better-than-expected earnings for its first quarter, while sales missed expectations. The company also lowered its sales forecast for the full year.